RATIONALE: Collecting and storing samples of blood from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at epidermal growth factor receptor mutations in the blood of patients with advanced non-small cell lung cancer.
OBJECTIVES: * Determine if epidermal growth factor receptor (EGFR) mutation exists in the peripheral blood of patients with advanced non-small cell lung cancer (NSCLC). * Estimate the frequency of EGFR mutation in these patients. * Correlate the presence of EGFR mutation in blood with EGFR mutation in primary or metastatic NSCLC tumor block. OUTLINE: Patients undergo blood collection for analysis of epidermal growth factor receptor mutation by DNA sequencing. PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study.
Study Type
OBSERVATIONAL
Enrollment
50
Alex Chang
Singapore, Singapore
Existence of epidermal growth factor receptor (EGFR) mutations in peripheral blood
Time frame: Day 1
Frequency of EGFR mutation
Number of participants with EGFR mutation in tissue and plasma.
Time frame: Day 1
Number of participants with EGFR mutation in peripheral blood and in tumor tissue.
Time frame: Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.